These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

277 related items for PubMed ID: 10096966

  • 1. Sirolimus (rapamycin) potentiates cyclosporine in prevention of acute lung rejection.
    Longoria J, Roberts RF, Marboe CC, Stouch BC, Starnes VA, Barr ML.
    J Thorac Cardiovasc Surg; 1999 Apr; 117(4):714-8. PubMed ID: 10096966
    [Abstract] [Full Text] [Related]

  • 2. Suppression of acute rejection in allogeneic rat lung transplantation: a study of the efficacy and pharmacokinetics of rapamycin derivative (SDZ RAD) used alone and in combination with a microemulsion formulation of cyclosporine.
    Hausen B, Boeke K, Berry GJ, Segarra IT, Christians U, Morris RE.
    J Heart Lung Transplant; 1999 Feb; 18(2):150-9. PubMed ID: 10194039
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Synergistic effect of low dose cyclosporine A and human interleukin 10 overexpression on acute rejection in rat lung allotransplantation.
    Pierog J, Gazdhar A, Stammberger U, Gugger M, Hyde S, Mathiesen I, Grodzki T, Schmid RA.
    Eur J Cardiothorac Surg; 2005 Jun; 27(6):1030-5. PubMed ID: 15896613
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Synergistic effect of vincristine with tacrolimus or sirolimus in prevention of acute heart allograft rejection in the rat.
    Jiang W, Jiang J, Xu D, Wang X, Qi S, Ouyang J, Ma A, Vu MD, Bilolo KK, Chen H.
    Microsurgery; 2003 Jun; 23(2):117-22. PubMed ID: 12740883
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Effect of sirolimus in combination with low-dose cyclosporine and steroids on acute renal allograft rejection.
    Tsai MK, Chueh SC, Hu RH, Lee PH.
    J Formos Med Assoc; 2003 Feb; 102(2):91-6. PubMed ID: 12709737
    [Abstract] [Full Text] [Related]

  • 14. Cyclosporine elimination in the presence of TOR inhibitors: effects on renal function, acute rejection, and safety.
    Velosa JA, Larson TS, Gloor JM, Stegall MD.
    Am J Kidney Dis; 2001 Oct; 38(4 Suppl 2):S3-S10. PubMed ID: 11583938
    [Abstract] [Full Text] [Related]

  • 15. Is the malononitrilamide FK778 better for the prevention of acute or chronic rejection?
    Deuse T, Schrepfer S, Pelletier MP, Fischbein MP, Robbins RC, Reichenspurner H.
    Transplant Proc; 2007 Mar; 39(2):569-72. PubMed ID: 17362784
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. A worldwide, phase III, randomized, controlled, safety and efficacy study of a sirolimus/cyclosporine regimen for prevention of acute rejection in recipients of primary mismatched renal allografts.
    MacDonald AS, RAPAMUNE Global Study Group.
    Transplantation; 2001 Jan 27; 71(2):271-80. PubMed ID: 11213073
    [Abstract] [Full Text] [Related]

  • 20. Coadministration of neoral and the novel rapamycin analog, SDZ RAD, to rat lung allograft recipients: potentiation of immunosuppressive efficacy and improvement of tolerability of staggered versus simultaneous treatment.
    Hausen B, Boeke K, Berry GJ, Segarra I, Benet LZ, Christians U, Morris RE.
    Transplantation; 1999 Apr 15; 67(7):956-62. PubMed ID: 10221478
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.